More than an hour before the U.S. Court of Appeals for the Federal Circuit was set to hear a closely watched gene-patent case, hundreds of observers had already gathered outside the National Courts Building in downtown Washington to snag a seat.

The rows in Courtroom 201 filled up quickly, and the appeals court promptly dug into the dispute — whether a human gene is patent-eligible under Section 101 of the Patent Act.